Piramal Pharma Limited
Largo

PPLPHARMA

385
IMPORTANT POINTS

1. RSI - 60 CROSSED ON MONTHLY CHART
2. CUP BREAKOUT OVER ONE YEAR
3. SECTOR BREAKOUT
4. Trading at 35.2% below our estimate of its fair value

FUNDAMENTALS

Below Fair Value

Significantly Below Fair Value

Price-To-Sales vs Peers

Price-To-Sales vs Industry

Price-To-Sales vs Fair Ratio
Nota
start breakout lets see
Nota
10% upward
Nota
become a rocket now
Nota
17 percent up
Nota
1 ST TARGET ACHIVE

Exención de responsabilidad

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.